0001127602-23-009138.txt : 20230306 0001127602-23-009138.hdr.sgml : 20230306 20230306174734 ACCESSION NUMBER: 0001127602-23-009138 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230306 DATE AS OF CHANGE: 20230306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAUNDERS BRENT L CENTRAL INDEX KEY: 0001268854 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41380 FILM NUMBER: 23710203 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD STREET 2: C/O SCHERING PLOUGH CORP CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch & Lomb Corp CENTRAL INDEX KEY: 0001860742 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 BUSINESS PHONE: 908-541-5456 MAIL ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 3/A 1 form3a.xml PRIMARY DOCUMENT X0206 3/A 2023-03-06 2023-03-06 0 0001860742 Bausch & Lomb Corp BLCO 0001268854 SAUNDERS BRENT L C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 ONTARIO, CANADA 1 1 CEO and Chair Common Shares, No Par Value 375000 D Non-Qualified Stock Options (right to purchase) 18.60 Common Shares, No Par Value 1318681 D Performance Stock Units 0 Common Shares, No Par Value 750000 D Reflects an award of restricted stock units ("RSUs") granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") on February 23, 2023. Each RSU reflects the right to receive one common share, no par value ("Common Share"), of Bausch + Lomb Corporation (the "Company"), subject to the terms of the Plan and the applicable award agreement. The RSUs are scheduled to vest 50% on the second anniversary of the grant date and the remaining 50% on the third anniversary of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date. Reflects an award of stock options to purchase Common Shares granted to the reporting person under the Plan on February 23, 2023. Each stock option reflects the right to purchase one Common Share, subject to the terms of the Plan and the applicable award agreement. The stock options are scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date. The stock options will expire on the tenth anniversary of the grant date. Represents an award of performance stock units ("PSUs") granted to the reporting person under the Plan on February 23, 2023. Each PSU reflects the right to receive one Common Share, subject to the terms of the Plan and the applicable award agreement. The target number of shares underlying the PSUs is 750,000 Common Shares, and the maximum number of shares underlying the PSUs is 2,250,000 Common Shares. The PSUs may be earned and vest between 0% and 300% based on achievement of specified share price performance goals (and, if applicable, a relative total shareholder return performance goal), calculated as of the fourth anniversary of the grant date (the "Measurement Date"), subject generally to the reporting person's continued employment through the Measurement Date. No equity changes to originally filed Form 3; submitting Form 3/A to include Limited Power of Attorney. /s/ Debra E. Levin, attorney-in-fact 2023-03-06 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): LIMITEDPOA POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints each of Christina M. Ackermann, Alex Matheson and Debra E. Levin, or any of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act") or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned, in the undersigned's capacity as a director and/or officer of Bausch + Lomb Corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section?16(a) of the Exchange Act and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5 complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney in fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys in fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. [REMAINDER OF PAGE INTENTIONALY LEFT BLANK] IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed on the date set forth below. By: /s/ Brent L. Saunders Name: Brent L. Saunders Date: March 6, 2023